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Aminopeptidase A activity and angiotensin III effects on metabolic pathways like gluconeogenesis and ammo-
[Ca21]i along the rat nephron. niagenesis, stimulation of expression of vascular endo-
Background. This study examined the specific effects of an- thelial growth factor, and regulation of renal tubular cellgiotensin III (Ang III) along the nephron.
growth [2–5]. These modulating effects are mediatedMethods. We examined the distribution of aminopeptidase
through interactions with specific receptors. The use ofA (APA) activity by using a specific APA inhibitor and by
immunostaining with an antirat kidney APA antibody, the peptidic and nonpeptidic antagonists has allowed the
Ang III-induced variations of [Ca21]i by using fura-2 and the identification of two major types of Ang II receptors,
characterization of the receptor subtype involved in the response
type I (AT1) and type II (AT2). Most known physiologicalto Ang III in cortical thick ascending limb (CTAL).
effects of Ang II seem to be mediated by AT1 receptors,Results. APA activity was found all along the nephron but
was higher in the cortex than in the medulla. This was confirmed whereas the physiological relevance of AT2 receptors is
by immunostaining. Increases in [Ca21]i elicited by 1027 mol/liter unclear. In rodents, two AT1 receptor (AT1-R) subtypes
Ang III were observed all along the nephron. The characteriza- have been isolated and termed AT1a and AT1b [6–10]. Intion of the receptor subtype involved in the [Ca21]i response
addition, the existence in the kidney of another specificto Ang III in CTAL indicated that EC50 values for Ang III
and Ang II were similar (13.5 and 10.3 nmol/liter, respectively), Ang III/Ang IV (non-AT1 and non-AT2) receptor(s) has
and Ang III-induced responses were totally abolished by AT1 been raised [11]. Recently, we examined the localization
receptor but not by AT2 receptor antagonists. There was a cross- of type I Ang II receptor subtypes, AT1a and AT1b, alongdesensitization of [Ca21]i responses to 1027 mol/liter Ang III the rat nephron. AT1a mRNA expression was largely pre-and Ang II, and the [Ca21]i responses to 1027 mol/liter Ang II
dominant in all nephron segments, whereas AT1a and AT1band Ang III were not additive.
Conclusion. These results show that in CTAL, the [Ca21]i mRNAs were both expressed in glomeruli and especially
responses to Ang II and Ang III occur through the same AT1a in mesangial cells [12, 13].
receptor because this subtype is predominant in this segment.
Although it is accepted that Ang II (Ang 1–8) is theTaken together, these data suggest that APA could be a key
biologically active peptide of the renin-angiotensin sys-enzyme to generate Ang III from Ang II in the kidney.
tem (RAS), it now appears that in some tissues Ang III
(Ang 2–8), its main metabolite, also could be an effector
of the RAS. In the brain, several studies suggested thatIn the kidney, angiotensin II (Ang II) plays a major
Ang II must be converted to Ang III to exert its biologi-role in the regulation of vascular resistance and glomeru-
cal effects [14]. This was recently demonstrated by Zinilar filtration. It is also well documented that Ang II
influences proximal and probably distal tubular trans- et al, who (a) identified aminopeptidase A (APA; EC
port, and may play an important role in the regulation 3.4.11.7) and aminopeptidase N (APN; EC 3.4.11.2) as
of renal medullary blood flow [1, 2]. Moreover, Ang II the enzymes responsible for the conversion, in the central
can exert other effects on the kidney such as action on the nervous system, of Ang II to Ang III and of Ang III to
glomerular processing of macromolecules, stimulation of angiotensin IV (Ang 3–8), respectively, and (b) by using
specific and selective inhibitors of these enzymes, showed
that the action of Ang II on vasopressin release dependsKey words: metalloprotease, intracellular calcium, angiotensin recep-
tor, microdissection, kidney. on the prior conversion of Ang II to Ang III [15]. In
adrenals, Ang II and Ang III are almost equipotent in
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important target organ for Ang II, but also is an impor- microscopic observation. Pieces of the following seg-
ments were isolated: glomerulus (Glom), proximal con-tant site for the metabolism of this hormone. This latter
function is due to the presence of a variety of peptidases voluted tubule (PCT), the straight part of the proximal
tubule taken from the medullary rays of the cortexin the kidney that are able to metabolize Ang II, includ-
ing membrane-bound aminopeptidases such as APA and (CPST) and from the outer stripe of the outer medulla
(OSPST), thick ascending limb from the outer medullaAPN or cytosolic aspartyl aminopeptidase [18], as well
as endopeptidases and carboxypeptidases [19]. Hydroly- (MTAL) and from the cortex (CTAL), collecting duct
from the cortex (CCD), and the outer medulla (OMCD).sis of Ang II to Ang III is the predominant first step in the
metabolism of circulating Ang II [20]. This conversion is
Measurement of aminopeptidase A enzymatic activityrealized in vitro [21] and in vivo in brain [15] by APA,
a membrane-bound zinc metalloprotease [22, 23]. This Aminopeptidase A activity was estimated by measuring
the hydrolysis of a synthetic substrate, a-l-glutamyl-b-ectoenzyme is largely distributed in peripheral tissues
and is particularly abundant in the kidney [24–27]. naphthylamide, in the absence or presence of EC33 (3-4-
amino-thiol butyl sulfonate), a specific APA inhibitorOur study aimed to specify the localization of a possi-
ble effect of Ang III along the nephron of rat kidney [28], according to the method previously described by
Zini et al [30]. Briefly, homogenates containing glomeruliby determining the following information on isolated
glomeruli and microdissected nephron segments: (a) the (three Glom) or tubular segments (<3 mm tubular length
for PCT, CPST and OSPST; <10 mm for CCD; <20 mmdistribution of APA enzymatic activity by using EC33,
a specific APA inhibitor [28], and by immunostaining for OMCD; <30 mm for CTAL; and <50 mm for MTAL)
were incubated at 378C (most of the time for 60 min orwith an antirat kidney APA antibody; (b) the variations
of intracellular calcium induced by a maximal dose of 120 to 240 min when tissue quantity obtained following
microdissection was not sufficient) in the presence ofAng III; and (c) the pharmacological characterization of
the receptor involved in the response to Ang III in the 200 mm/liter of a-l-glutamyl-b-naphthylamide, 4 mm/liter
CaCl2, 1 mm/liter bestatin inhibitor with or without 5 mm/cortical thick ascending limb, a segment in which the re-
ceptor subtype AT1a has been previously well defined [12]. liter EC33 in a final volume of 100 ml of 50 mm/liter Tris-
HCl buffer, pH 7.4. Bestatin, a nonspecific aminopepti-
dase inhibitor, was used at 1 mm to prevent the degradation
METHODS
of the substrate by other aminopeptidases such as B, N,
Animals W, and cytosolic leucine aminopeptidases. At this con-
centration, bestatin does not inhibit aminopeptidase AAll animal procedures were conducted in agreement
with our institutional guidelines for the care and use activity [31–33]. The reaction was stopped by the addition
of 10 ml of 3 N HCl. In order to determine the 2-naphthyla-of laboratory animals. Male Sprague-Dawley rats (Iffa
Credo, L’Arbresle, France), weighing 130 to 180 g, were mine liberated by substrate hydrolysis using diazotation,
25 ml of 0.6% NaNO2 in aqueous solution was added,used. They were kept under artificial light (12 hr light/
12 hr dark cycle) and were fed normal standard diet and the samples were incubated for two minutes. Then
50 ml of 1.5% ammonium sulfamate were added, fol-(Usine Alimentation Rationnelle, Epinay-sur-Orange,
France; A03) and offered water ad libitum. lowed by a further two-minute incubation. Twenty-five
microliters of 0.6% N-(1-naphthyl)-ethylenediamine di-
Microdissection of nephron segments hydrochloride (in 95% ethanol) were added, and the
samples were incubated for 30 minutes at 378C. TheAnimals were anesthetized by intraperitoneal injec-
tion of pentobarbital (6 mg/100 g body wt). The left absorbance was monitored at 560 nm and compared with
the optical density (OD) recovered with different stan-kidney was prepared for nephron microdissection by in-
fusion of 5 ml of basal medium (composition in mmol/ dard concentrations of 2-naphthylamine (up to 0.15 mm)
determined in parallel. To estimate the specific amino-liter: NaCl, 137; KCl, 5; MgSO4, 0.8; Na2HPO4, 0.33;
KH2PO4, 0.44; MgCl2, 1; CaCl2, 1; HEPES, 20; glucose, 5; peptidase A activity, the OD from the assay with EC33
was subtracted from the OD without the inhibitor. Thelactate, 5; acetate, 10; pyruvate, 1; glutamine, 2; aspartate,
0.3) containing 0.2% collagenase (Serva, Vienna, Aus- activities were expressed in nmol 2-naphthylamine/hr/
Glom or mm tubular length and in nmol 2-naphthyla-tria) through a catheter placed in the aorta just below
the left renal artery, as previously described [29]. The mine/hr/mg protein (for protein determination we used
values reported by Nonoguchi, Takehara, and Endou [34]).kidney was then removed and sliced along the cortico-
medullary axis. Small pyramids were cut and incubated
Immunolocalizationin 0.1% collagenase solution in basal medium bubbled
with filtered air at 308C for 15 minutes. Glomeruli and Rats (adult males) anesthetized with sodium pentobar-
bital were fixed by aortic perfusion of paraformaldehydenephron segments were isolated by microdissection in
basal medium without collagenase at 48C under stereo- [2.5 or 4% in phosphate-buffered saline (PBS) for 10 to
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20 min]; kidneys were removed, cut in two halves, and model (least-squares criterion, Gauss Newton algorithm)
using commercially available software [37].postfixed overnight in the same solution. Half kidneys
were dehydrated in graded ethanol and butanol-1 and
were embedded in paraffin following a routine technique.
RESULTS
Seven-micrometer thick sections were cut, mounted on
Aminopeptidase A activity measurement along thehistological slides, deparaffinized, and rehydrated in PBS.
rat nephronSections were then processed through the usual steps of
an immunoperoxidase technique with a rabbit antirat Before studying APA activity along the rat nephron,
we verified in our assay conditions that the productionAPA as primary antibody [26] diluted 1:2000, a goat
biotynylated antirabbit secondary antibody (Vectastain, of 2-naphthylamine by isolated Glom increased linearly
with glomeruli number for a 60-minute incubation time.Vector; Burlingame, CA, USA), and the ABC-Elite
(Vectastain) amplification system, with DAB and hydro- The production of 2-naphthylamine was linear up to
about 20 glomeruli and was saturable beyond this valuegen peroxide as chromogen and substrate for peroxidase.
(the equation of the linear regression line drawn on the
Measurements of intracellular calcium concentration graph is the following: y 5 1.92x 2 0.78, r 5 0.998, P ,
0.01). Production of 2-naphthylamine by Glom was alsoIntracellular calcium ([Ca21]i) was measured as pre-
viously described [35]. After microdissection, each Glom well correlated with an incubation time of up to four
hours (y 5 0.07x 2 0.02, r 5 0.990, P , 0.01). In addition,or isolated tubule (0.2 to 0.3 mm) was transferred individ-
ually onto a thin glass microscope coverslip in 1 ml basal no difference in the metabolic production of 2-naphthyl-
amine was found in Glom from collagenase-treated kid-medium containing 2 mmol/liter CaCl2 and 1% agarose
(type IX). Then the agarose was jellied by cooling the ney (1.78 6 0.42 nmol/hr/Glom) and untreated (1.76 6
0.05 nmol/hr/Glom). Blanks (without homogenate) runslide for two minutes on ice. The samples embedded in
agarose were loaded with 5 mmol/liter Fura-2 AM at in parallel for each experiment were equivalent to the
values obtained in the presence of EC33, showing that inroom temperature for approximately one hour. For flu-
orescence measurements, each sample was placed on the our assay conditions (60 min incubation), the measured
enzymatic activity only corresponded to APA activity.stage of an inverted microscope and was continuously
superfused at a rate of 0.8 ml/min at 378C with basal When the incubation periods of the different nephron
segments were extended, we observed that hydrolysis ofmedium (2 mmol/liter CaCl2), which could be replaced
at any time by the solutions to be tested. In most experi- a-l-glutamyl-b-naphthylamide in the presence of EC33
was different than the blanks at 120 minutes and thereaf-ments, Ang III and/or antagonists were continuously
applied for five minutes, avoiding peptide degradation. ter remained stable up to 240 minutes, whatever the
considered segment (21.6 6 2.8% at 120 min, 19.0 6The Fura-2–loaded Glom or piece of tubule was alterna-
tively excited at wavelengths of 340 and 380 nm (every 1.7% at 180 min, and 22.9 6 4.0% at 240 min). In good
agreement with these data, in a control experiment per-4 seconds) using a 75 W xenon light source, filters, and
a chopper (PTI Photoscan II System; Kontron, Munchen, formed in Glom, the percentage of hydrolysis of a-l-
glutamyl-b-naphthylamide in the presence of EC33 wasGermany). The illumination path included a 403 objec-
tive (Nikon, Tokyo, Japan) and an ultraviolet dichroic also different than the blanks after 60 minutes (19%
for 120 min, 22% for 180 min, and 30% for 240 min).mirror. Emitted signals passed through a 510 nm band-
pass filter before detection by a photomultiplier. The However, whatever the incubation time, APA activities
in Glom, calculated by the difference between a-l-gluta-measured fluorescence intensities (S at 340 nm and L at
380 nm) were recorded from a selected area delimited by myl-b-naphthylamide hydrolysis values obtained in the
absence or presence of EC33 were equivalent and repro-an adjustable window diaphragm. [Ca21]i was calculated
using the equation of Grynkiewicz, Poenie, and Tsien [36]: ducible: 1.39 6 0.07 nmol/hr/Glom (mean 6 sem ob-
tained for the incubation times of 30, 60, 120, 180, and
[Ca21]i 5 Kd [(R 2 Rmin)/(Rmax 2 R)] (Lmax/Lmin) 240 min).
Figure 1 shows the distribution of APA activity alongwhere the dissociation constant, Kd 5 224 nm, R 5 S/L,
and Lmax, Lmin, Rmin, and Rmax are L and R values at 0 and the rat nephron. APA activity was significantly detected
all along the nephron. Substantial activity was found insaturating concentrations of calcium, respectively. Lmax,
Lmin, Rmin, and Rmax were determined by external calibra- glomeruli and proximal parts. In the cortex, APA activity
increased from the PCT to the CPST. The results alsotion as previously described by Taniguchi, Marchetti,
and Morel [35]. indicated that APA activity was higher in cortical than
in medullary segments. A decreasing gradient was suc-All of the results are mean values of replicate samples 6
sem (or sd in a few instances). Statistical differences were cessively observed between CPST and OSPST, CTAL
and MTAL, and OMCD versus CCD, with 2.6-, 4.2-, andassessed using Student’s t-test for unpaired data. EC50
was estimated by fitting the data to a nonlinear regression 3.6-fold differences between the values of APA activity
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Fig. 1. Enzymatic aminopeptidase A activity
along the rat nephron. Values are mean 6
sem from four to six individual determinations.
Metabolic production of 2-naphthylamine was
expressed either in nmol/hr/Glom or mm tu-
bular length (A), or in nmol/hr/mg protein (B).
*P , 0.05; **P , 0.01.
measured in the cortical and medullary segments. There collagenase, homogeneous and reproducible results were
obtained all along the nephron, except in proximal parts.was no striking difference when results were expressed
either per mm (Fig. 1A) or per mg of protein (Fig. 1B), For this reason, PCT and CPST were microdissected in
the absence of collagenase, and calcium measurementsexcept for glomeruli, where APA activity was signifi-
cantly higher than in PCT when results were expressed were performed as described by Champigneulle et al
[38]. Moreover, it was verified that similar results wereper mg of protein; note that using this latter representa-
tion to compare Glom and PCT was probably more ap- obtained in the presence or absence of collagenase in
Glom and CTAL.) In these three latter structures wherepropriate.
the intensity of the calcium response was lower, there
Immunohistochemical localization of aminopeptidase A was a longer sustained calcium phase compared with
in rat kidney the other segments, in which we observed a sharp peak
followed by a rapid return to the basal level. We notedIn agreement with the preceding observation, Figure
2 shows that in the rat kidney, the APA immunoperoxi- also that basal levels were different according to the
considered structures: (a) <50 nmol/liter in CTAL anddase signal was much higher in cortical than in medullary
segments. In the cortex, glomeruli and PCTs showed an MTAL; (b) <100 nmol/liter in Glom, CCD, and OMCD;
and (c) <200 nmol/liter in PCT and CPST. In addition,intense immunostaining (Fig. 2 A, B), located exclusively
at the apical brush border of PCT cells (Fig. 2B) and in it is noteworthy that all along the nephron except for
the Glom, there was a correlation between calcium peakmesangial cells of the Glom (Fig. 2D). In contrast, in
the medulla (Fig. 2F), the last portion of the pars recta values and measurements of APA activities, whatever
the mode of expression used: per mm of tubular length(OSPST) exhibited a weaker level of APA expression
compared with PCT. In this segment, the staining was (y 5 0.005x 2 0.523, r 5 0.930, N 5 6, P , 0.01) or per
mg of protein (y 5 0.029x 2 1.132, r 5 0.897, N 5 6,also clearly located at the apical brush border. In addi-
tion, a low signal was observed in the medulla, probably P , 0.01).
in the MTAL (Fig. 2F). As a negative control, normal
Pharmacological characterization of [Ca21]i responserabbit serum (NRS) was used, and in these experimental
to angiotensin III in CTALconditions, a section of rat cortex did not reveal any
significant immunostaining in the apical brush border of In consideration of (a) the amplitude of the calcium
peak induced by 1027 mol/liter Ang III in CTAL, whichPCT or in Glom (Fig. 2 C, E).
appears lower than in PCT and CPST but was sufficiently
[Ca21]i response induced by angiotensin III along high for an accurate evaluation, (b) the predominant
the nephron expression of the AT1a subtype mRNA [approximately
94% of total AT1 (AT1a 1 AT1b) mRNA] [12], and (c) the[Ca21]i variations induced by 1027 mol/liter Ang III
and mean values of peak [Ca21]i responses (D[Ca21]i) are good cellular viability observed in CTAL, this nephron
segment was selected to perform the pharmacologicalpresented in Figure 3. Increases of intracellular calcium
was observed all along the nephron. However, calcium characterization of the calcium response to Ang III.
Dose–response curve. The dose-dependency of Ang IIIresponses induced by 1027 mol/liter Ang III were signifi-
cantly higher in PCT, CPST, MTAL, and CTAL than in for calcium mobilization in CTAL is shown in Figure 4.
The maximum response was obtained at 1027 mol/literGlom, CCD, and OMCD. (Note that in the presence of
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Fig. 2. Immunoperoxidase staining of aminopeptidase A (APA) in adult rat kidney. In the cortex, APA is revealed in PCT cells (A), at the apical
brush border (B), and in the glomeruli (A, arrows), probably at the plasma membrane of mesangial cell (D). Note that the staining is stronger in
the inner cortex than the outer cortex (A). In the outer medulla, the APA immunostaining is localized in the last portion of pars recta (F, arrows)
and, at a much weaker level, in MTAL (F, arrowheads). Control staining with normal rabbit serum in cortex (C) and glomerulus (E) is shown.
There was no counterstaining. Bar is 500 mm (A and C) or 50 mm (B, D, E, and F).
of Ang III, and the half maximum response was equal tion of 1027 mol/liter Ang II (19 6 3 vs. 206 6 21 nmol/
liter, N 5 5; Fig. 5A), and to (b) 1027 mol/liter Ang IIto 1.35 6 0.52 1028 mol/liter.
Effects of type 1 and type 2 receptor antagonists losartan after a first application of 1027 mol/liter Ang III (62 6 12
vs. 209 6 24 nmol/liter, N 5 6; Fig. 5B). It is importantand PD 123319 on angiotensin III-induced calcium re-
sponses. Table 1 shows that the calcium responses in- to note that homologous desensitization behaved the
same when two successive applications of Ang II (24 6 3duced by 1027 mol/liter Ang III were totally abolished
by 1026 mol/liter losartan and not by 1026 mol/liter PD vs. 209 6 17 nmol/liter, N 5 13) or Ang III (37 6 7 vs.
201 6 36 nmol/liter, N 5 5) were performed (Fig. 5 C, D,123319. These results indicate that the calcium response
to Ang III in CTAL is mediated by an AT1 receptor. respectively). These decreases in calcium responses ob-
served after a second application of Ang II or Ang IIICross-desensitization of [Ca21]i responses by 1027 mol/
liter angiotensin II and III. Clearly, Figure 5 indicates were not due to cell deterioration, because a third appli-
cation of 1027 mol/liter bradykinin elicited a typical cal-that in CTAL, there was cross-desensitization because
there was a significant decrease in the calcium level in cium response with a standard magnitude (264 6 31
nmol/liter, N 5 5).response to (a) 1027 mol/liter Ang III after a first applica-
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Fig. 3. Representative recordings of intracel-
lular calcium levels in response to 1027 mol/
liter Ang III along the nephron. Mean values
(D[Ca21]i 6 sem) of peak responses are indi-
cated for each structure. D[Ca21]I is the varia-
tion in intracellular calcium concentration ex-
pressed as the peak increase in [Ca21]i above
basal values.
Absence of additional angiotensin II and III effects in Indeed, the calcium response observed in the presence
of the two hormones was similar to that of Ang II orCTAL. Calcium responses induced by 1027 mol/liter
Ang II and 1027 mol/liter Ang III, alone or in combina- Ang III alone.
Absence of an effect of angiotensin IV on the calciumtion, were measured in a series of eight different experi-
ments using CTAL. Table 2 gives the average values of response in CTAL. To evaluate the specificity of the
calcium response induced by Ang III in CTAL samples,this series. No additional effects could be obtained in
this nephron segment when the two hormones were used we studied the effect of 1027 mol/liter Ang IV. In our
experimental conditions, 1027 mol/liter Ang IV did notin concentrations that induced maximal responses [12].
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of proximal tubule and lower levels in other segments
[25]. More accurately, immunohistochemical analysis of
the cellular distribution of APA in the kidney shows
a strongly positive staining: (a) at the surface of the
glomerular endothelial cells, the visceral and parietal
layers of Bowman’s capsule, and the juxtaglomerular
apparatus [39]; (b) in glomerular mesangial cells [27];
and (c) at the surface of the glomerular epithelial cells
[40]. In contrast, Mentzel et al demonstrate by immu-
noelectron microscopy that APA is located on the cell
membrane of podocytes but not on the endothelial or
mesangial cells [41].
Angiotensin III effects on intracellular
calcium concentrations
Fig. 4. Dose–response curve to angiotensin (Ang) III in cortical thick No study of the calcium response to Ang III along theascending limb (CTAL). Half-maximal effective response was 13.5 6
nephron has been reported so far. Our results show that5.0 nmol/liter (mean 6 sd). D[Ca21]i is the variation in intracellular
calcium concentration expressed as the peak increase in [Ca21]i above calcium increases elicited by 1027 mol/liter Ang III were
basal values. Each point represents the mean calculated from 5 to 10 observed all along the nephron. Intracellular calciumindividual determinations.
responses were the higher in PCT, CPST, CTAL, and
MTAL and the lower in Glom, CCD, and OMCD. Inter-
estingly, these responses were similar to those obtained
Table 1. Pharmacological characterization of AT1 and AT2 receptor along the nephron with equimolar doses of Ang II [12].
antagonists in rat CTAL This latter observation is in good agreement with other
No. of D[Ca21]i study findings that in human astrocytes Ang III was as
Conditions experiments nmol /liter effective as Ang II in increasing calcium mobilization
1027 mol /liter Ang III 4 197 611 [42] and in adrenocortical Y-1 cells, where Ang II and
1027 mol /liter Ang III Ang III were also almost equipotent in terms of calcium1 1026 mol /liter losartan 3 ND
mobilization [43].1027 mol /liter Ang III
1 1026 mol /liter PD 123319 4 204621
Pharmacological characterizationAbbreviations are: AT, angiotensin receptor type; Ang, angiotensin; CTAL,
cortical thick ascending limb; D[Ca21]i, change in intracellular calcium concentra- The experiments were performed in order to study thetion; ND, not detectable. Values are means 6 sem.
pharmacological characterization of the receptor type
involved in the calcium response to Ang III in CTAL.
They show that: (a) EC50 values for Ang III (1.35 1028
elicit calcium response (data not shown). We also verified mol/liter) and Ang II (1.03 1028 mol/liter) [12] were of
that this absence of calcium response was not due to cell the same order of magnitude. (b) The Ang III-induced
viability, because in a series of three experiments, 1027 calcium responses were totally abolished by AT1 (losar-
mol/liter Ang III or Ang II applied after a first exposure tan) but not by AT2 (PD 123319) receptor antagonists. (c)
to Ang IV was able to induce a calcium response with There was a cross-desensitization of calcium responses to
a normal amplitude: 250 6 31 and 238 6 8 nmol/liter, 1027 mol/liter Ang III and Ang II. (d) Calcium responses
respectively. to Ang III and Ang II were not additive. (e) Intracellular
calcium was not affected in this segment by Ang IV, in
contrast to Ang III and Ang II. Taken together, theseDISCUSSION
results indicate that in CTAL, the calcium responses to
Distribution of aminopeptidase A activity along Ang III and Ang II occurred through the same AT1
the nephron receptor type, and more precisely the subtype AT1a, as we
By using a specific APA inhibitor, this work provides have previously shown that this isoform is predominantly
evidence, to our knowledge for the first time, that sig- found in this segment [12]. These data were confirmed
nificant APA activity is present all along the nephron. in other systems. In the brain, compared with Ang II,
Our results indicate that APA activity is higher in cortical Ang III at a dose of 1027 mol/liter produced a similar
than in medullary segments. This observation was con- increase in intracellular calcium and blocked subsequent
firmed with our data obtained by immunostaining. In responses to Ang II, suggesting that activation also oc-
the same manner, Sudo and Tanabe have shown high curred through the same angiotensin receptor subtype [42].
In AT1a- and AT1b-transfected adrenal cells, the compar-levels of “APA-like” activities in the segment 2 (PT2)
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Fig. 5. Representative recordings of intracellular calcium levels in response to two successive applications of: (i) 1027 mol/liter angiotensin (Ang)
II and 1027 mol/liter Ang III (A); (ii) 1027 mol/liter Ang III and 1027 mol/liter Ang II (B); (iii) 1027 mol/liter Ang II (C); and (iv) 1027 mol/liter
Ang III (D) in CTAL. Mean values of peak responses are indicated in the text.
Table 2. Absence of additivity of Ang II and Ang III effects in rat CTAL Putative physiological roles of aminopeptidase A in
the kidneyNo. of D[Ca21]i
Conditions experiments nmol /liter Aminopeptidase A preferentially cleaves in vitro the
1027 mol /liter Ang II 17 204 618 NH2-terminal glutamyl or aspartyl residue from peptide1027 mol /liter Ang III 10 210 626
substrates [21]. In vivo this enzyme is involved in the1027 mol /liter Ang II
1 1027 mol /liter Ang III 9 217624 conversion of brain Ang II to Ang III by removing the
NH2-terminal aspartyl residue from Ang II [15]. Further-Values are means 6 sem. Abbreviations are in Table 1 legend.
more, in the central nervous system, the close correspon-
dence between the distribution of APA activity, angioten-
sin receptors and angiotensin nerve terminals, associated
ison of the dose–response curves for Ang II and Ang III with the observation that APA activity is overactivated
revealed that Ang III was almost as potent as Ang II in in the spontaneously hypertensive rat [30] strongly sug-
evoking calcium responses (EC50: Ang II, 2.5 1029 mol/ gests that APA is an integral component of the RAS.
liter; Ang III, 3.5 1029 mol/liter for AT1a-transfected cells, In the kidney, the parallelism between the distribution
and Ang II, 2.0 1029 mol/liter; Ang III, 4.8 1029 mol/liter along the nephron of APA activity, calcium responses
for AT1b-transfected cells) [43]. elicited by Ang III, Ang I-converting enzyme activity [47]
In CTAL, Ang IV was without effect, and this empha- and Ang II receptors [26] supports a similar conclusion.
sized the specificity of the calcium response induced by APA could play an important role in modulating the
Ang III. Nevertheless, the AT4 receptor was widely dis- activity of both circulating and locally produced Ang II.
tributed in the kidney [44]. AT4 receptors have been Song et al have proposed that APA may have multiple
described in opossum kidney cells, and Ang IV induced a physiological functions within the kidney, depending on
transient increase in intracellular calcium concentration its localization, for example, metabolism of oligopeptides
caused by an increase in calcium influx [45]. Chansel et in the glomerular filtrate and degradation/conversion of
al also described AT4 receptors in rat mesangial cells circulating or intrarenally synthesized bioactive peptides,
and have shown that Ang IV stimulated cytosolic calcium including Ang II [26]. Wolf, Assmann, and Stahl demon-
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